Complete response to an anti-programmed cell death 1 antibody following a combination therapy of an anti-programmed cell death ligand 1 antibody and a tyrosine kinase inhibitor for metastatic renal cell carcinoma

Autor: Kurokawa, Masayuki, Naito, Sei, Kato, Tomoyuki, Ushijima, Masaki, Yamagishi, Atsushi, Sakurai, Toshihiko, Nishida, Hayato, Tsuchiya, Norihiko
Zdroj: In Asian Journal of Urology January 2023 10(1):103-105
Databáze: ScienceDirect